These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37731635)

  • 1. Retraction: CAR-NK Cell: a new paradigm in tumor immunotherapy.
    Frontiers Editorial Office
    Front Oncol; 2023; 13():1285219. PubMed ID: 37731635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CAR-NK Cell: A New Paradigm in Tumor Immunotherapy.
    Marofi F; Al-Awad AS; Sulaiman Rahman H; Markov A; Abdelbasset WK; Ivanovna Enina Y; Mahmoodi M; Hassanzadeh A; Yazdanifar M; Stanley Chartrand M; Jarahian M
    Front Oncol; 2021; 11():673276. PubMed ID: 34178661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy.
    Pan K; Farrukh H; Chittepu VCSR; Xu H; Pan CX; Zhu Z
    J Exp Clin Cancer Res; 2022 Mar; 41(1):119. PubMed ID: 35361234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DAP12-based activating chimeric antigen receptor for NK cell tumor immunotherapy.
    Töpfer K; Cartellieri M; Michen S; Wiedemuth R; Müller N; Lindemann D; Bachmann M; Füssel M; Schackert G; Temme A
    J Immunol; 2015 Apr; 194(7):3201-12. PubMed ID: 25740942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retraction: A novel tumor suppressor gene, ZFN24, inhibits the development of NSCLC by inhibiting the Wnt signaling pathway to induce cell senescence.
    Frontiers Editorial Office
    Front Oncol; 2022; 12():1045516. PubMed ID: 36237304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retraction: CRISPR/Cas9-Mediated OC-2 Editing Inhibits the Tumor Growth and Angiogenesis of Ovarian Cancer.
    Frontiers Editorial Office
    Front Oncol; 2021; 11():694036. PubMed ID: 34041039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retraction: MicroRNA-326 functions as a tumor suppressor in breast cancer by targeting ErbB/PI3K signaling pathway.
    Frontiers Editorial Office
    Front Oncol; 2023; 13():1298871. PubMed ID: 37881488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retraction: Chitosan-Coated Titanium Dioxide-Embedded Paclitaxel Nanoparticles Enhance Anti-Tumor Efficacy Against Osteosarcoma.
    Frontiers Editorial Office
    Front Oncol; 2021; 11():712966. PubMed ID: 34178703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retraction: Long noncoding RNA SNHG1 activates autophagy and promotes cell invasion in bladder cancer.
    Office FE
    Front Oncol; 2023; 13():1228367. PubMed ID: 37377910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retraction: OTUB2 facilitates tumorigenesis of gastric cancer through promoting KDM1A-mediated stem cell-like properties.
    Frontiers Editorial Office
    Front Oncol; 2023; 13():1209867. PubMed ID: 37287909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retraction: Downregulation of hsa_circ_0001836 Induces Pyroptosis Cell Death in Glioma Cells
    Frontiers Editorial Office
    Front Oncol; 2021; 11():840877. PubMed ID: 35036362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retraction: LINC00337 Regulates KLF5 and Maintains Stem-Cell Like Traits of Cervical Cancer Cells by Modulating miR-145.
    Frontiers Editorial Office
    Front Oncol; 2021; 11():840051. PubMed ID: 35036358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retraction: STAT3 Promotes Invasion and Aerobic Glycolysis of Human Oral Squamous Cell Carcinoma
    Frontiers Editorial Office
    Front Oncol; 2021; 11():761874. PubMed ID: 34557422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retraction: LncRNA SNHG19 Promotes the Development of Non-Small Cell Lung Cancer
    Frontiers Editorial Office
    Front Oncol; 2021; 11():840907. PubMed ID: 35087764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retraction: The Collective Effect of MIP-3α and FL Promotes Dendritic Cell Function Within the Immune Microenvironment of Murine Liver Cancer.
    Frontiers Editorial Office
    Front Oncol; 2021; 11():744389. PubMed ID: 34497774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical application and prospect of immune checkpoint inhibitors for CAR-NK cell in tumor immunotherapy.
    Yang K; Zhao Y; Sun G; Zhang X; Cao J; Shao M; Liang X; Wang L
    Front Immunol; 2022; 13():1081546. PubMed ID: 36741400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retraction: LINC01315 impairs microRNA-211-dependent DLG3 downregulation to inhibit the development of oral squamous cell carcinoma.
    Frontiers Editorial Office
    Front Oncol; 2024; 14():1378198. PubMed ID: 39026977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retraction: New insights into molecular signalling pathways and current advancements in prostate cancer diagnostics and therapeutics.
    Frontiers Editorial Office
    Front Oncol; 2023; 13():1343833. PubMed ID: 38130994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retraction: Combination of Tanshinone IIA and Cisplatin Inhibits Esophageal Squamous Cell Carcinoma by Down-Regulating NF-kB/COX-2/VEGF Pathway.
    Frontiers Editorial Office
    Front Oncol; 2021; 11():721658. PubMed ID: 34277459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chimeric antigen receptor (CAR)-transduced natural killer cells in tumor immunotherapy.
    Hu Y; Tian ZG; Zhang C
    Acta Pharmacol Sin; 2018 Feb; 39(2):167-176. PubMed ID: 28880014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.